Osteopontin aggravates experimental autoimmune uveoretinitis in mice

Area of Science:

• Immunology
• Ophthalmology
• Molecular Biology

Background:

• Human endogenous uveitis is a prevalent, sight-threatening intraocular inflammatory condition.
• Experimental autoimmune uveoretinitis (EAU) in mice is a widely used model to study uveitis, potentially mediated by Th1 immune responses.
• Osteopontin (OPN) is a protein with diverse functions, known to influence Th1 cell-mediated immunity.

Purpose of the Study:

• To investigate the role of osteopontin (OPN) in the development and progression of experimental autoimmune uveoretinitis (EAU).
• To evaluate the therapeutic potential of targeting OPN in a murine model of uveitis.

Main Methods:

• Utilized wild-type (WT) and osteopontin-deficient (OPN-/-) mice immunized with human interphotoreceptor retinoid-binding protein (hIRBP) peptide 1-20 to induce EAU.
• Assessed clinical and histopathological scores to evaluate EAU severity.
• Analyzed T cell proliferation and proinflammatory cytokine (TNF-alpha, IFN-gamma) production in response to antigen stimulation.
• Administered M5 antibody, which targets a cryptic binding site on OPN, to WT mice during EAU induction.

Main Results:

• OPN levels were elevated in WT mice during EAU progression.
• OPN-deficient mice exhibited significantly milder EAU compared to WT mice.
• T cells from OPN-deficient mice showed reduced antigen-specific proliferation and proinflammatory cytokine production.
• Administration of M5 antibody to WT mice significantly ameliorated EAU development and reduced T cell responses.

Conclusions:

• Osteopontin (OPN) contributes to the pathogenesis of experimental autoimmune uveoretinitis (EAU).
• Targeting OPN, for example, with the M5 antibody, can effectively suppress EAU.
• OPN represents a promising novel therapeutic target for controlling uveitis.